Study S000180

Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00569907
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 18
Start: 2007-01
Primary completion: 2009-05
Lead sponsor: HealthPartners Institute
Conditions: Diabetes Mellitus Type 2
Results posted: FALSE

Registered primary outcomes

None registered.

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0022664	Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. DeFronzo RA, Diabetes care	2005	Randomized trial	PMID 15855572 DOI	registry reference BACKGROUND:15855572
R0022827	Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Buse JB, Diabetes care	2004	Randomized trial	PMID 15504997 DOI	registry reference BACKGROUND:15504997